W.R. Berkley Operating Cash Flow decreased by 32.9% to $667.86M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.2%, from $743.82M to $667.86M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 13.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $384.82M | $828.59M | $659.59M | $477.68M | $527.97M | $767.65M | $795.30M | $445.32M | $708.75M | $1.08B | $698.08M | $746.24M | $881.33M | $1.24B | $810.03M | $743.82M | $703.81M | $1.14B | $995.13M | $667.86M |
| QoQ Change | — | +115.3% | -20.4% | -27.6% | +10.5% | +45.4% | +3.6% | -44.0% | +59.2% | +52.0% | -35.2% | +6.9% | +18.1% | +40.8% | -34.7% | -8.2% | -5.4% | +62.0% | -12.7% | -32.9% |
| YoY Change | — | — | — | — | +37.2% | -7.4% | +20.6% | -6.8% | +34.2% | +40.3% | -12.2% | +67.6% | +24.4% | +15.2% | +16.0% | -0.3% | -20.1% | -8.1% | +22.9% | -10.2% |